Literature DB >> 322712

The use of a phospholipase A-less Escherichia coli mutant to establish the action of granulocyte phospholipase A on bacterial phospholipids during killing by a highly purified granulocyte fraction.

J Weiss, P Elsbach.   

Abstract

Phospholipase A2 present in a highly purified, potently bactericidal, fraction from rabbit graulocytes produces net bacterial phospholipid degradation during killing of a phospholipase A-less strain of Escherichia coli. In the wild-type parent strain phospholipid breakdown is caused not only by the action of phospholipase A2 but also by phospholipase A1, indicating activation of the most prominent phospholipase of E. coli. This activation occurs as soon as the bacteria are exposed to the granulocyte fraction. Phospholipid breakdown by both phospholipases A is dose dependent but reaches a plateau after 30-60 min and at higher concentrations of the fraction. Phospholipid degradation is accompanied in both strains by an increase in permeability to actinomycin D that is also dose dependent. Even though net hydrolysis of phospholipids is greater in the parent strain than in the mutant, the increase in permeability is the same in the two strains. The addition of 0.04 M Mg2+, after the effects on phospholipids and permeability have become manifest, initiates in both strains the restoration of insensitivity to actinomycin D, the net resynthesis of phospholipids, and the disappearance of monoacylphosphatides and the partial disappearance of free fatty acids that had accumulated. Loss of ability to multiply is not reversed by Mg2+ in either strain. Less than 5 micrograms of granulocyte fraction causes loss of viability of from 90 to 99% of 1 X 10(8) microorganisms of both strains. However, at lower concentrations the parent strain is considerably more sensitive to the bactericidal effect of the granulocyte fraction than the mutant strain.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 322712     DOI: 10.1016/0005-2736(77)90205-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Determinants of activation by complement of group II phospholipase A2 acting against Escherichia coli.

Authors:  L M Madsen; M Inada; J Weiss
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Low concentrations of indomethacin inhibit phospholipase A2 of rabbit polymorphonuclear leukocytes.

Authors:  L Kaplan; J Weiss; P Elsbach
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

3.  Enzymology, genetics, and regulation of membrane phospholipid synthesis in Escherichia coli.

Authors:  C R Raetz
Journal:  Microbiol Rev       Date:  1978-09

4.  The preparation, properties and action on Staphylococcus aureus of purified fractions from the cationic proteins of rabbit polymorphonuclear leucocytes.

Authors:  E Walton
Journal:  Br J Exp Pathol       Date:  1978-08

5.  Effect of leukocyte hydrolases on bacteria. XIII. Role played by leukocyte extracts, lysolecithin, phospholipase a2, lysozyme, cationic proteins, and detergents in the solubilization of lipids from Staphylococcus aureus and group A streptococci: relation to bactericidal and bacteriolytic reactions in inflammatory sites.

Authors:  M Lahav; N Ne'eman; M N Sela; I Ginsburg
Journal:  Inflammation       Date:  1979-09       Impact factor: 4.092

6.  Bacterial phospholipid hydrolysis enhances the destruction of Escherichia coli ingested by rabbit neutrophils. Role of cellular and extracellular phospholipases.

Authors:  G C Wright; J Weiss; K S Kim; H Verheij; P Elsbach
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

7.  Influence of organic solvent mixtures on biological membranes.

Authors:  C Gustafson; C Tagesson
Journal:  Br J Ind Med       Date:  1985-09

8.  Platelet-activating factor and phospholipase A2 in patients with septic shock and trauma.

Authors:  J Sörensen; B Kald; C Tagesson; M Lindahl
Journal:  Intensive Care Med       Date:  1994-11       Impact factor: 17.440

9.  Resistance of gram-negative bacteria to purified bactericidal leukocyte proteins: relation to binding and bacterial lipopolysaccharide structure.

Authors:  J Weiss; S Beckerdite-Quagliata; P Elsbach
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

10.  Role of charge and hydrophobic interactions in the action of the bactericidal/permeability-increasing protein of neutrophils on gram-negative bacteria.

Authors:  J Weiss; M Victor; P Elsbach
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.